SPECTRA OPTIA 12220

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional report with the FDA on 2020-02-14 for SPECTRA OPTIA 12220 manufactured by Terumo Bct.

Event Text Entries

[185699340] Investigation: the customer provided terumo bct customer support with photographs of the connector and the front of the machine, from which the tbct customer support specialist could see hemolysis in the connector and plasma line. The plasma in the plasma line was a cherry color. A disposable history search was performed for lot 1911123130. One other similar issue was reported by the same customer. Investigation is in process. A follow-up report will be provided.
Patient Sequence No: 1, Text Type: N, H10


[185699341] The customer reported that 3 minutes into a therapeutic plasma exchange (tpe) procedure on a pediatric patient, they received the alarm 'cells were detected in plasma line from centrifuge'. The operator stated that she performed custom prime with red cells; the patient's tbv is 952ml. This patient has history of developing clots, so she is on heparin. The operator was having issues with the access line which was very positional. The operator stated that the replacement fluid is fresh frozen plasma (ffp) and the type is compatible. The patient has had a heart transplant and she has tpe procedures twice per week; today is the first treatment of the week. The operator stated that no clots were visible in the channel or set. The patient did not receive any hemolyzed components form the channel or the reservoir. The physician asked the operator to terminate the procedure, set up the machine again, perform a custom prime, and continue. No other labs were ordered by the physician and no testing was ordered on the unit or the patient. No medical intervention was required for the patient after the terminated procedure. The operator stated that the patient did great in the second procedure. They did not send the blood prime unit for testing, but they determined the alleged hemolysis was likely related to the blood from the custom prime that was in still in the channel at the time it was observed. The patient is in stable condition. The customer declined to provide the patient identifier. The disposable set is not available for return because it was discarded by the customer
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1722028-2020-00062
MDR Report Key9711534
Report SourceHEALTH PROFESSIONAL
Date Received2020-02-14
Date of Report2020-02-14
Date of Event2020-01-22
Date Mfgr Received2020-01-22
Device Manufacturer Date2019-11-12
Date Added to Maude2020-02-14
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactSCOT HILDEN
Manufacturer Street10810 W. COLLINS AVE
Manufacturer CityLAKEWOOD CO 80215
Manufacturer CountryUS
Manufacturer Postal80215
Manufacturer Phone3032314970
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameSPECTRA OPTIA
Generic NameSPECTRA OPTIA EXCHANGE SET
Product CodeLKN
Date Received2020-02-14
Catalog Number12220
Lot Number1911123130
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerTERUMO BCT
Manufacturer AddressLAKEWOOD CO 80215 US 80215


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2020-02-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.